Client News

Global launch of cosmetic product based on AFYREN’s 100% natural propionic acid

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial

AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers

Novogenia AG Publishes H1 2026 Issuer Report and Advances Strategic Growth Initiatives in Core Business Areas

EU-Funded Q-AID Project Deploys First POLARIS Systems for Quantum-Enhanced MRI Network

AFYREN announces its 2026 half-year financial results

Life Science Intelligence partners with Opus Origin to accelerate the expansion of its premium global platforms for medtech innovation and investment